Adaptive Immune Responses in Periodontitis

Overview of Adaptive Immunity

• General Characteristics:     * Provides specific protection against pathogens.     * Utilizes antigen-specific receptors: T-Cell Receptor ($TCR$) and B-Cell Receptor ($BCR$).     * Provides immunological memory, allowing for a faster and more robust response upon re-exposure.     * Activated cell subsets include memory cells for long-term immunity.

• T-Lymphocytes (Cell-Mediated Immunity):     * Responsible for the direct lysis of infected cells.     * Production of various cytokines to coordinate the immune response.

• B-Lymphocytes (Humoral Immunity):     * Differentiate into antibody-producing plasma cells.     * Effector functions of antibodies include:         * Neutralization: Preventing the interaction of pathogens and their products (such as toxins) with host cells.         * Opsonization: Enhancing phagocytosis and the killing of pathogens by innate cells like neutrophils ($PMNs$) and macrophages.         * Complement Activation: Activating the classical pathway of the complement system.

• Major Lymphocyte Subsets:     * $CD8^+$ Cytotoxic T-Lymphocytes (CTLs): Express $CD8$ with the $TCR$, interacting with $MHC-I$. They produce a wide range of cytotoxic compounds to kill virally infected cells and cancer cells.     * $CD4^+$ Helper T-Lymphocytes (Th cells): Express $CD4$ with the $TCR$, interacting with $MHC-II$. They produce cytokines and chemokines to enhance the function of innate cells and B-lymphocytes.     * $CD4^+$ Regulatory T-Lymphocytes (Treg cells): Suppress the activity of other immune cells to maintain homeostasis.     * $CD4^+$ Th17 T-lymphocytes: A specific subset involved in inflammation and defense against extracellular pathogens.

Immunopathogenesis of Periodontitis Lesions

• Progression to Established Lesions ($4$-$21$ days):     * Neutrophils ($PMNs$) decrease in number within the tissue, while lymphocytes and macrophages increase.     * By Day $21$, lymphocytes dominate the infiltrate ($70\%$), while $PMNs$ account for less than $10\%$.     * $PMNs$ increase within the junctional epithelium, forming a protective barrier.     * $CD4$ to $CD8$ T-cell ratio is observed at approximately $2:1$.     * Langerhans cells (antigen-presenting cells) present antigens to sensitized T cells.     * A $Th1$ immune response at this stage can contain the infection, resulting in a "stable lesion."     * Chronic gingivitis is the result of persistent plaque and incomplete bacterial clearance.

• Progressive and Advanced Lesions:     * Plasma cells and lymphocytes become predominant.     * High levels of cytokines $IL-1$ and $IL-6$ are present.     * Increased epithelial permeability allows for the ingress of microbial products and further cytokine production ($IL-1$, $TNF-\alpha$, and $PGE_2$).     * Cytokines stimulate the release of Matrix Metalloproteinases ($MMPs$) from fibroblasts and macrophages, leading to the degradation of the extracellular matrix.     * Advanced lesions are characterized by clinically evident attachment loss and alveolar bone loss.

Immune Cell Subsets in Disease and Health

• Single-Cell Sequencing Insights:     * T cells remain the major immune cell population in both healthy and diseased oral mucosa (including $CD4^+$, $Th17$, $MAIT$, $\alpha\beta$ $CD8^+$, $\gamma\delta$ $T$, $Treg$, and $NK/T$ cells).     * B cells and plasma cells represent the next largest population.     * Plasma cells are significantly expanded in periodontitis compared to health.     * Neutrophils also expand in diseased tissue as part of the myeloid/granulocyte population.

• Relative Abundance: T lymphocytes are the largest cell type in gingival tissue regardless of disease state.

Role of T Lymphocytes in Periodontitis and Bone Loss

• Lymphocyte Requirement: Research using $SCID$ mice (which lack T and B lymphocytes) shows that lymphocytes are required for alveolar bone loss in mouse models of periodontitis.

• $CD8$ Lymphocytes:     * $\beta_2$-microglobulin-deficient mice (lacking $MHC$ class $I$ and functional $CD8^+$ T cells) developed normal alveolar bone loss following infection.     * There is no convincing evidence that $CD8^+$ T cells directly contribute to tissue destruction during disease progression.     * Most periodontal pathogens are extracellular, meaning their peptides are presented via $MHC$ class $II$ to $CD4^+$ T cells.     * Increased activation markers (e.g., $CD28$) on $CD8$ lymphocytes in disease may merely reflect general tissue inflammation.

• $CD4$ Lymphocytes:     * $A\beta$ knockout mice (lacking $MHC$ class $II$ and functional $CD4^+$ T cells) developed reduced alveolar bone loss following infection.     * $CD4$ lymphocytes are critical drivers of alveolar bone loss.

Characterization of $CD4^+$ T Lymphocyte Subsets

• The "Signal 3" Differentiation Model:     * $Th1$ Phenotype: Induced by $IL-12$.     * $Th2$ Phenotype: Induced by $IL-4$.     * $Th17$ Phenotype: Induced by $TGF-\beta$ and $IL-6$.     * $Treg$ Phenotype: Induced by $TGF-\beta$ alone.

• $Th1$ Cells in Periodontitis:     * Produce Interferon-gamma ($IFN\gamma$).     * $IL-12$ is primarily produced by myeloid cells (macrophages, $DCs$) and promotes $Th1$ maturation.     * $Th1$ response is important for stable lesions and helps APCs.     * $IFN\gamma$ is increased in periodontitis patients; it activates macrophage bactericidal functions and dendritic cell maturation.     * However, $IFN\gamma$ produced by $IL-12$ activated $CD4$ cells also drives the progression of bone loss in advanced lesions.

• $Th2$ Cells in Periodontitis:     * Produce $IL-4$, $IL-5$, and $IL-10$.     * Regulate humoral immunity (antibody-mediated) and provide cytokines for B cell activation.     * Directly antagonize $Th1$ immunity and reduce inflammation.     * Drive macrophages toward an $M2$ anti-inflammatory phenotype.     * Experimental data shows that the presence of $IL-4$ reduces alveolar bone loss.

• $Th17$ Cells in Periodontitis:     * Secrete signature cytokines: $IL-17$, $IL-6$, and $IL-22$.     * Amplify inflammatory responses and are prominent in chronic inflammatory diseases.     * $IL-17$ levels correlate with periodontitis severity.     * Mechanisms of Destruction: $IL-17$ stimulates $MMP$ and inflammatory cytokine expression in gingival fibroblasts and macrophages. It also stimulates $RANKL$ expression (e.g., by osteoblasts), promoting bone resorption.     * Effercytosis Connection: Macrophages clearing apoptotic neutrophils (which have degraded bacteria) can drive a $Th17$ response, resulting in an increased $RANKL/OPG$ ratio and osteoclast induction.

• Regulatory T-Cells (Treg) in Periodontitis:     * Secrete signature cytokines: $TGF\beta$ and $IL-10$.     * $IL-10$ is protective; $IL-10$ knockout mice exhibit a hyper-inflammatory phenotype and increased alveolar bone loss.     * $FoxP3$ is the transcriptional regulator used as a marker for Tregs.     * Plasticity: Historically, Tregs and $Th17$ cells were viewed as distinct, but evidence shows "plasticity." Both require $TGF-\beta$ for development, but $Th17$ cells also require an inflammatory environment. Double-positive $IL-17^+/FoxP3^+$ cells have been detected in periodontitis tissue.

B-Lymphocytes and Antibodies in Periodontitis

• Abundance and Phenotype:     * Plasma cells are the most abundant immune cell infiltrate in advanced lesions with bone loss.     * Healthy gingiva contains predominantly "memory" B-lymphocytes.     * Periodontitis triggers a shift from memory B cells toward mature, antibody-secreting plasma cells.

• Dual Role of B Cells:     * Protective: Production of antibodies is generally beneficial in preventing infection.     * Destructive: B cells can also produce $RANKL$ and $IL-1\beta$, which promote osteoclastogenesis and bone resorption.

• Antibody Characteristics:     * $IgA$ and $IgG$ are produced locally in the periodontium.     * Antibodies against all suspected periodontal pathogens (e.g., $P. gingivalis$) are detectable in serum and gingival crevicular fluid ($GCF$).     * Subclass Distribution: Many studies report a predominance of $IgG2$ antibodies. $IgG2$ has weak complement activation and opsonization but binds inflammatory $Fc\gamma$ receptors.

• Clinical Correlations:     * Positive correlation between probing depth and $IgG2$ antibody levels (associated with $Fc\gamma Ri/ITAM$ pathways).     * Negative correlation between probing depth and $IgG4$ antibody levels (associated with $Fc\gamma Riib/ITIM$ pathways).     * $IgG4$ is often directed against adhesin epitopes of Gingipains (major virulence factors of $P. gingivalis$).

Summary and Systemic Implications

• Systemic Links: Chronic periodontal inflammation is linked to systemic conditions, including Rheumatoid Arthritis, Diabetes, Cancer, and Atherosclerosis.

• Immune Balance:     * Pro-inflammatory ($Th1$): Produces $IL-1\beta$, $TNF\alpha$; induces $RANKL$. Necessary for pathogen control but causes bone loss.     * Anti-inflammatory ($Th2/Treg/M2$): Produces $IL-4$, $IL-10$; induces $OPG$ to reduce $RANKL$ availability. Necessary to regulate inflammation and protect bone.

• Innate-Adaptive Synergy: The systems do not exist in isolation. The adaptive system depends on the innate system for antigen presentation and cytokines. The innate system requires helper T cell cytokines for full activation and antibodies for opsonization.

• Final Perspective: Inflammation is host-protective if produced at the appropriate time, level, and duration. When regulation is maintained, periodontal health persists; when regulation fails, periodontitis occurs.